Art

J-GLOBAL ID：200902180188613756   Reference number：97A0141804

Recommended Dose of Flutamide with LH-RH Agonist Therapy in Patients with Advanced Prostate Cancer.

進行前立腺癌患者に対するLH-RHアゴニスト療法に併用するフルタミドの適正用量

Author (7)： AKAZA H (Univ. Tsukuba, Tsukuba, JPN) ,  ISAKA S (Univ. Chiba, Chiba, JPN) ,  USAMI M (Center for Adult Disease Osaka, Osaka, JPN) ,  KANETAKE H (Nagasaki Univ. School of Medicine, Nagasaki, JPN) ,  KOTAKE T (Center for Adult Disease Osaka, Osaka, JPN) ,  KOISO K (Univ. Tsukuba, Tsukuba, JPN) ,  ASO Y (Fujieda Municipal General Hospital, Fujieda, JPN)
Material： International Journal of Urology  (Int J Urol)
Volume： 3  Issue： 6  Page： 468-471  Publication year： Nov. 1996 
JST Material Number： L2870A  ISSN： 0919-8172  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： prostatic tumor ,...
Semi thesaurus term： LH-RH ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=97A0141804&from=J-GLOBAL&jstjournalNo=L2870A") }}

JST classification (2)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (12)：

• MCLEOD, D. Controversies in the treatment of metastatic prostate cancer. Cancer. 1992, 70, 324-328
• DENIS, L. J. Goserelin acetate and flutamide versus bilateral orchiectomy, a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center. Urology. 1993, 42, 119-129
• AKAZA, H. Flutamide, and pure antiandrogen, as monotherapy in a prospective study of prostatic cancer in Japan. J Urol. 1992, 147, 417A
• DELAERE, K. P. Flutamide monotherapy as primary treatment inadvanced prostatic carcinoma. Semin Oncol. 1991, 18, suppl 6, 13-18
• WYSOWSKI, D. K. Flutamide hepatotoxicity. J Urol. 1996, 155, 209-212

Terms in the title (7)： 前立腺癌 ,  患者 ,  LH-RHアゴニスト ,  療法 ,  併用 ,  フルタミド ,  適正用量